Wright Medical Group Price Target Increased to $37.00 by Analysts at Leerink Swann (WMGI)
Leerink Swann increased their price target on shares of Wright Medical Group (NASDAQ:WMGI) from $31.00 to $37.00 in a research note issued on Friday, Analyst Ratings News reports. Leerink Swann’s target price suggests a potential upside of 14.87% from the company’s current price.
In other Wright Medical Group news, SVP Jennifer S. Walker unloaded 6,050 shares of Wright Medical Group stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $32.00, for a total value of $193,600.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
A number of other firms have also recently commented on WMGI. Analysts at Barclays raised their price target on shares of Wright Medical Group from $28.00 to $30.00 in a research note to investors on Thursday, January 9th. They now have an “equal weight” rating on the stock. Separately, analysts at RBC Capital raised their price target on shares of Wright Medical Group from $26.00 to $28.00 in a research note to investors on Tuesday, November 12th. They now have a “sector perform” rating on the stock. Finally, analysts at Piper Jaffray raised their price target on shares of Wright Medical Group from $34.00 to $35.00 in a research note to investors on Tuesday, November 5th. They now have an “overweight” rating on the stock. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $30.73.
Wright Medical Group (NASDAQ:WMGI) last posted its quarterly earnings results on Monday, November 4th. The company reported ($0.18) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.18). The company had revenue of $57.64 million for the quarter, compared to the consensus estimate of $56.30 million. During the same quarter in the previous year, the company posted $0.01 earnings per share. The company’s revenue for the quarter was down 47.8% on a year-over-year basis.
Wright Medical Group, Inc, through Wright Medical Technology, Inc (NASDAQ:WMGI) and other operating subsidiaries (Wright), is a global orthopaedic medical device company specializing in the design, manufacture and marketing of devices and biologic products for extremity, hip and knee repair and reconstruction.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.